Brind.
  1. Travere Therapeutics, Inc. presented abstracts at a congress held in Kyoto.

Cyclo Therapeutics, a subsidiary of Rafael Holdings, presented research on Trappsol Cyclo designed to impact NPC1 in Kyoto.

1 report, 1 independent Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cyclo Therapeutics, a subsidiary of Rafael Holdings, presented research on Trappsol Cyclo designed to impact NPC1 in Kyoto.

Who's involved

What this event is mainly about
Rafael Advanced Defense SystemsNPC

Keep exploring

Part of

Travere Therapeutics, Inc. presented abstracts at a congress held in Kyoto. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireRafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) NEWARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -